Search research articles
Contact Us
Filters
Showing results (331-340 of 342) with videos related to
Page
of 35
Sort By:
Signal Transduction and Targeted Therapy
|
June 5, 2026
Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors
Chaitra Rai, Hang Ruan, Xue Li, et al.
Nature Communications
|
November 13, 2020
In-plane uniaxial pressure-induced out-of-plane antiferromagnetic moment and critical fluctuations in BaFe<sub>2</sub>As<sub>2</sub>
Panpan Liu, Mason L Klemm, Long Tian, et al.
Biomed Research International
|
April 4, 2014
GCK gene-body hypomethylation is associated with the risk of coronary heart disease
Limin Xu, Dawei Zheng, Lingyan Wang, et al.
Iscience
|
October 27, 2025
Single-cell and spatial transcriptomics reveal intratumor heterogeneity and immune evasion in natural killer/T cell lymphoma
Shuyun Ma, Biaojie Huang, Jiahui Wang, et al.
American Journal of Hematology
|
August 27, 2021
Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer/T-cell lymphoma: A multicenter study
Yuchen Zhang, Shuyun Ma, Jun Cai, et al.
Journal for Immunotherapy of Cancer
|
June 13, 2025
ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function
Yu Zhang, Feng Yu, Jing Ouyang, et al.
Cancer Medicine
|
April 19, 2022
Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study
Yuchen Zhang, Panpan Liu, Jun Cai, et al.
Nature Communications
|
April 11, 2025
Highly dynamic and sensitive NEMOer calcium indicators for imaging ER calcium signals in excitable cells
Wenjia Gu, Jia-Hui Chen, Yiyin Zhang, et al.
Biomedical Reports
|
October 4, 2014
Association between <i>LGALS2</i> 3279C>T and coronary artery disease: A case-control study and a meta-analysis
Jiangfang Lian, Peiliang Fang, Dongjun Dai, et al.
Cancer Medicine
|
May 3, 2025
Chidamide, a Histone Deacetylase Inhibitor, Combined With R-GemOx in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (TRUST): A Multicenter, Single-Arm, Phase 2 Trial
Qihua Zou, Yuchen Zhang, Hui Zhou, et al.
Page
of 35
Search research articles
Search
Showing results (331-340 of 342) with videos related to
Sort By:
Page
of 35
Signal Transduction and Targeted Therapy
|
June 5, 2026
Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors
Chaitra Rai, Hang Ruan, Xue Li, et al.
Nature Communications
|
November 13, 2020
In-plane uniaxial pressure-induced out-of-plane antiferromagnetic moment and critical fluctuations in BaFe<sub>2</sub>As<sub>2</sub>
Panpan Liu, Mason L Klemm, Long Tian, et al.
Biomed Research International
|
April 4, 2014
GCK gene-body hypomethylation is associated with the risk of coronary heart disease
Limin Xu, Dawei Zheng, Lingyan Wang, et al.
Iscience
|
October 27, 2025
Single-cell and spatial transcriptomics reveal intratumor heterogeneity and immune evasion in natural killer/T cell lymphoma
Shuyun Ma, Biaojie Huang, Jiahui Wang, et al.
American Journal of Hematology
|
August 27, 2021
Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer/T-cell lymphoma: A multicenter study
Yuchen Zhang, Shuyun Ma, Jun Cai, et al.
Journal for Immunotherapy of Cancer
|
June 13, 2025
ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function
Yu Zhang, Feng Yu, Jing Ouyang, et al.
Cancer Medicine
|
April 19, 2022
Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study
Yuchen Zhang, Panpan Liu, Jun Cai, et al.
Nature Communications
|
April 11, 2025
Highly dynamic and sensitive NEMOer calcium indicators for imaging ER calcium signals in excitable cells
Wenjia Gu, Jia-Hui Chen, Yiyin Zhang, et al.
Biomedical Reports
|
October 4, 2014
Association between <i>LGALS2</i> 3279C>T and coronary artery disease: A case-control study and a meta-analysis
Jiangfang Lian, Peiliang Fang, Dongjun Dai, et al.
Cancer Medicine
|
May 3, 2025
Chidamide, a Histone Deacetylase Inhibitor, Combined With R-GemOx in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (TRUST): A Multicenter, Single-Arm, Phase 2 Trial
Qihua Zou, Yuchen Zhang, Hui Zhou, et al.
Page
of 35